Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Share Price    (AIDL)

Here is the latest stock price and chart of ASTRAZENECA PHARMA. For more details, see the ASTRAZENECA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.

EV Stocks: A Hidden Way to Tap into the Massive 15x EV Opportunity

REFRESH
Live BSE Quotes Oct 22, 2021 09:07:00 AM
Price (Rs)3,144.95 Open (Rs) 0.00 High (Rs) 0.00 Low (Rs) 0.00
% Change3.05 Volume 0 Value (Rs) 0 52-Week H/L 4,900.00 / 3,000.00
Live NSE Quotes Oct 22, 2021 9:07:43 AM
Price (Rs)3,053.80 Open (Rs) 3,053.80 High (Rs) 3,053.80 Low (Rs) 3,053.80
% Change0.00 Volume 10 Value (Rs) 30,538 52-Week H/L 4,910.00 / 3,005.00
Change
1 Day
3.05%
1 Month
1.62%
3 Months
-10.15%
1 Year
-25.67%
5 Years (CAGR)*
25.60%
10 Years (CAGR)*
10.10%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 33.96 P/E Ratio (x) 92.60 Market Cap (Rs m) 78,623.75 P/BV (x) 17.30 Dividend Yield (%) 0.06
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

ASTRAZENECA PHARMA Share Price Today:

ASTRAZENECA PHARMA share price is up 3.1% to Rs 3,145.0 on the BSE. On the NSE, the ASTRAZENECA PHARMA share price is up 0.0% to Rs 3,053.8. The total volume of shares traded is 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index is trading up by 0.1%. And the benchmark S&P BSE SENSEX is at 61,045.1 (up 0.2%).

Over the last 30 days, the ASTRAZENECA PHARMA share price is up 0.9%. And over the last one year, ASTRAZENECA PHARMA share price is down 27.1%.

The current market capitalisation of ASTRAZENECA PHARMA stands at Rs 78,623.75 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of September 2021, company promoters held 75.00% stake in ASTRAZENECA PHARMA, with no shares having been pledged. To know more, check out the latest shareholding pattern of ASTRAZENECA PHARMA.


What else is happening in the markets today? Dig in...


Today's Market

SGX Nifty Up 29 Points; Indicates Positive Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a positive note today. At 8:15 am, it was trading up by 29 points, or 0.2% higher at 18,270 levels.

Related Views On News

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 45.0% (Quarterly Result Update)

Aug 11, 2021 | Updated on Aug 11, 2021

For the quarter ended June 2021, ASTRAZENECA PHARMA has posted a net profit of Rs 102 m (down 45.0% YoY). Sales on the other hand came in at Rs 2 bn (down 9.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY21); Net Profit Up 184.8% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, ASTRAZENECA PHARMA has posted a net profit of Rs 273 m (up 184.8% YoY). Sales on the other hand came in at Rs 2 bn (up 7.9% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

Modi's Big Move Could Boost these 5 Defence Stocks (Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution (Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You... (Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally (Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 8-QTR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS